Q3 EPS Estimates for Immix Biopharma Raised by HC Wainwright
Immix Biopharma, Inc. (NASDAQ:IMMX – Free Report) – Equities research analysts at HC Wainwright boosted their Q3 2025 earnings estimates for Immix Biopharma in a note issued to investors on Wednesday, June 4th. HC Wainwright analyst R. Burns now anticipates that the company will post earnings of ($0.16) per share for the quarter, up from […]
Immix Biopharma, Inc. (NASDAQ:IMMX – Free Report) – Equities research analysts at HC Wainwright boosted their Q3 2025 earnings estimates for Immix Biopharma in a note issued to investors on Wednesday, June 4th. HC Wainwright analyst R. Burns now anticipates that the company will post earnings of ($0.16) per share for the quarter, up from […]
